Cite
HARVARD Citation
Brenneis, C. et al. (n.d.). Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495). Osteoarthritis and cartilage. pp. S299-S300. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brenneis, C. et al. (n.d.). Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495). Osteoarthritis and cartilage. pp. S299-S300. [Online].